Zhejiang Hisun Pharmaceutical Co., Ltd. (SHA:600267)

China flag China · Delayed Price · Currency is CNY
10.79
-0.27 (-2.44%)
Aug 28, 2025, 2:45 PM CST
-2.44%
Market Cap12.65B
Revenue (ttm)9.69B
Net Income (ttm)546.88M
Shares Out1.17B
EPS (ttm)0.47
PE Ratio22.87
Forward PE25.76
Dividend0.21 (1.90%)
Ex-Dividend DateMay 16, 2025
Volume37,294,797
Average Volume33,685,903
Open11.05
Previous Close11.06
Day's Range10.55 - 11.14
52-Week Range6.95 - 13.06
Beta0.45
RSI36.62
Earnings DateAug 26, 2025

About SHA:600267

Zhejiang Hisun Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biological and generic drugs in China. The company provides active pharmaceutical ingredients and finished dosage form products. It offers products for anti-tumor, anti-infection, cardiovascular, endocrine, immunosuppression, antidepressant, liver care, and orthopaedics treatment; and weight loss, anti-viral, anti-TB, animal healthcare, and others. The company also exports its products to approximately 70 countries worldwide. The company was fo... [Read more]

Sector Healthcare
Founded 1956
Employees 7,994
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600267
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.